Study Stopped
Inclusion rate too low.
The Effect of Virtual Reality on Pulmonary Recovery and Mobility in Patients With Blunt Chest Trauma
VIREX PURE
1 other identifier
interventional
27
1 country
1
Brief Summary
Blunt chest trauma comprises over 10% of all trauma patients presenting to emergency departments worldwide and is the most frequent injury in polytrauma patients. It is associated with high risk (\>10%) of pulmonary complications such as pneumonia. Pillars of treatment are adequate pain relief, respiratory function exercises and rapid mobilisation through physiotherapy. Inadequate pain control can result in restricted ventilatory function and in reduced mobility, both resulting in a higher risk of particularly pulmonary complications. Virtual Reality (VR) might be an easy to use, individualized, and harmless technique that can facilitate pulmonary recovery and aid in the prevention of complications through reducing pain and promoting exercising. The investigators hypothesize that VR improves respiratory function and mobilisation in the post-acute phase of blunt chest trauma by distracting patients from pain and stress, and by stimulating pulmonary and physical exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2022
CompletedFirst Posted
Study publicly available on registry
January 18, 2022
CompletedStudy Start
First participant enrolled
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2023
CompletedMarch 8, 2023
March 1, 2023
11 months
January 2, 2022
March 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Inspiration volume, mean change from baseline
Mean change from baseline in inspiration volume in ml, measured with an incentive spirometer (Voldyne)
From baseline to end of treatment at day 5.
Inspiration volume, repeated measures over 5 days
change in mean daily inspiration volume in mL, measured with an incentive spirometer (Voldyne)
Twice daily from enrollment to day 5 of treatment
Secondary Outcomes (8)
Time spent sitting or standing, mean change from baseline
Continuously from enrollment to end of treatment at day 5.
Length of hospital stay
At end of follow-up, 30 days after discharge
Pulmonary complications during admission
At end of follow-up, 30 days after discharge
Transfers to ICU
At end of follow-up, 30 days after discharge
Readmission within 30 days
At end of follow-up, 30 days after discharge
- +3 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONThe control group will receive usual care. Patients will be instructed to perform respiratory exercises 8 times daily for 10 minutes and to extend these exercises 2 times daily with (sitting) physical exercises for an additional 10 minutes. Respiratory exercises include using incentive spirometry and exercises for deep breathing, huffing and coughing. Patients receive a leaflet with the exercises described and the exercises will be performed once daily under supervision of a physiotherapist. The other sessions will be unsupervised.
Virtual Reality
EXPERIMENTALThe intervention group will be instructed to perform the respiratory exercises using the VR-intervention 8 times daily for 10 minutes and to extend these exercises 2 times daily with (sitting) physical exercises for an additional 10 minutes. The respiratory exercises in VR are comparable to the exercises in usual care but performed in a virtual environment and without incentive spirometry. The physical exercises consist of several games through which patients are challenged to reach out to objects while engaging their core. Patients are allowed to continue these exercises or play some relaxation games for up to 30 minutes per session in total. The exercises will be performed once daily under supervision of a physiotherapist. The other sessions will be unsupervised.
Interventions
For all VR exercises a head mounted display (HMD), the PICO G2 4K (Barcelona, Spain) will be used. Together with SyncVRMedical (Utrecht, Netherlands) a VR dashboard has been created from which patients can chose the different exercises.
Eligibility Criteria
You may qualify if:
- Admitted to the trauma ward with sustained blunt chest trauma
- Age≥16
- Patient is willing and able to comply with the study protocol
You may not qualify if:
- Neurotrauma with GCS ≤13
- History of dementia, seizures, epilepsy
- Severe hearing/visual impairment not corrected
- Head wounds or damaged skin with which comfortable and hygienic use is not possible.
- Stay at intensive care unit (ICU) during current hospital admission.
- Erect position in bed not possible/allowed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud university medical center
Nijmegen, Gelderland, 6525 GA, Netherlands
Related Publications (1)
Groenveld TD, Smits IG, Scholten N, de Vries M, van Goor H, Stirler VM. Pulmonary and Physical Virtual Reality Exercises for Patients With Blunt Chest Trauma: Randomized Clinical Trial. JMIR Serious Games. 2024 Dec 9;12:e54389. doi: 10.2196/54389.
PMID: 39652866DERIVED
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2022
First Posted
January 18, 2022
Study Start
March 28, 2022
Primary Completion
February 23, 2023
Study Completion
February 23, 2023
Last Updated
March 8, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ANALYTIC CODE
Non-identifiable patient characteristics, questionnaire data, diaries and measurements will be shared in a pseudonimised manner in DANS EASY under restricted access